8Nijsten TE,Stem RS.The increased risk of skin cancer is persistent after discontinuation of psoralen+uhraviolet A : a cohort study[J].J In- vest Dermato1,2003,121(2) :252.
4Cameron H, Dawe RS, Yule S, et al. A randomized, observer-blinded trial of twice vs.three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis.Br J Dermatol, 2002, 147: 973-978.
5Markham T, Rogers S, Collins P. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. Arch Dermatol, 2003, 139: 325-328.
6Gordon PM, Diffey BL, Matthews JN, et al.A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol. 1999, 41: 728-732.
7Messer G, Degitz K, Plewig G, et al. Pretreatment of psoriasis with the vitamin D3derivative tacalcitol increases the responsiveness to 311-nm ultraviolet B: results of a controlled, right/left study. Br J Dermatol,2001, 144: 628-629.
8Hofmann UB, Eggert AA, Brocker EB, et al. Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm)in psoriasis. Br J Dermatol, 2003, 148:779-783.
9Schiener R, Behrens-Williams SC, Pillekamp H, et al. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis. Br J Dermatol, 2000,143: 1275-1278.
10Novak Z, Bonis B, Baltas E, et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J Photochem Photobiol B, 2002, 67: 32-38.
